<DOC>
	<DOCNO>NCT01492374</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacodynamic effect BMS-241027 cerebrospinal fluid ( CSF ) Tau , connectivity magnetic resonance imaging ( MRI ) , computerized cognitive test mild Alzheimer 's disease ( AD ) subject , follow 9 weekly intravenous ( IV ) infusion BMS-241027</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability Effect BMS-241027 Cerebrospinal Fluid Biomarkers Subjects With Mild Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Mild AD Subjects meet National Institute Neurological Disorders Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) Diagnostic Statistical Manual Mental DisordersForth Edition , Text Revision ( DSMIVTR ) criteria MiniMental State Exam ( MMSE ) Score 20 &amp; 26 ( inclusive ) CSF consistent AD pathology Screening brain MRI normal commensurate age demonstrate atrophy consistent AD diagnosis ( dx ) ; reveal mild white matter disease ; 2 lacunar infarct acceptable except anterior thalamus , genu internal capsule basal forebrain ; reveal cortical infarct ; reveal 4 microbleeds ; reveal focal asymmetric lobar atrophy finding suggest primary cause dementia attribute cause AD ; reveal macrohemorrhages ( &gt; 10 mm ) Subjects must reliable study partner Men Women Non Child Bearing Potentia ( WONCBP ) , age 5090 year Subjects medical condition mild AD could explain subject ' memory cognitive deficit Subjects diagnose moderate severe AD per DSMIV criterion Subjects history ( hx ) stroke Subjects hx GI illnesses Subjects Vitamin B12 folate deficiency Subjects unstable cardiovascular ( CV ) , pulmonary , Gastrointestinal ( GI ) hepatic disease within 30 day prior screen Subjects active liver dx history hepatic intolerance Subjects Geriatric Depression Scale score â‰¥ 6 screen Subjects treat diagnosis schizophrenia Subjects treat diagnosis bipolar disease within 3 year prior screen Subjects history generalize peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>